Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
Collaboration streamlines patient access to oncology clinical trials
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Inducts advanced AI-Powered 24x7 remote patient monitoring system
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Subscribe To Our Newsletter & Stay Updated
